Year |
Citation |
Score |
2020 |
Muniraj N, Siddharth S, Shriver M, Nagalingam A, Parida S, Woo J, Elsey J, Gabrielson K, Gabrielson E, Arbiser JL, Saxena NK, Sharma D. Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment. Cell Death Discovery. 6: 81. PMID 32963809 DOI: 10.1038/S41420-020-00315-W |
0.37 |
|
2018 |
Ackermann MA, Shriver M, Perry NA, Hu LR, Kontrogianni-Konstantopoulos A. Correction: Obscurins: Goliaths and Davids Take over Non-Muscle Tissues. Plos One. 13: e0190842. PMID 29298356 DOI: 10.1371/Journal.Pone.0190842 |
0.66 |
|
2017 |
Stroka KM, Wong BS, Shriver M, Phillip JM, Wirtz D, Kontrogianni-Konstantopoulos A, Konstantopoulos K. Loss of giant obscurins alters breast epithelial cell mechanosensing of matrix stiffness. Oncotarget. 8: 54004-54020. PMID 28903319 DOI: 10.18632/Oncotarget.10997 |
0.693 |
|
2017 |
Sengupta S, Nagalingam A, Muniraj N, Bonner MY, Mistriotis P, Afthinos A, Kuppusamy P, Lanoue D, Cho S, Korangath P, Shriver M, Begum A, Merino VF, Huang CY, Arbiser JL, et al. Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3. Oncogene. PMID 28581518 DOI: 10.1038/onc.2017.164 |
0.391 |
|
2016 |
Stroka KM, Wong BS, Shriver M, Phillip JM, Wirtz D, Kontrogianni-Konstantopoulos A, Konstantopoulos K. Loss of giant obscurins alters breast epithelial cell mechanosensing of matrix stiffness. Oncotarget. PMID 27494856 DOI: 10.18632/oncotarget.10997 |
0.674 |
|
2016 |
Shriver M, Marimuthu S, Paul C, Geist J, Seale T, Konstantopoulos K, Kontrogianni-Konstantopoulos A. Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit. Oncotarget. PMID 27323778 DOI: 10.18632/Oncotarget.9985 |
0.714 |
|
2015 |
Shriver M, Stroka KM, Vitolo MI, Martin S, Huso DL, Konstantopoulos K, Kontrogianni-Konstantopoulos A. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis Oncogene. 34: 4248-4259. PMID 25381817 DOI: 10.1038/Onc.2014.358 |
0.712 |
|
2015 |
Kontrogianni-Konstantopoulos A, Shriver M, Perry N, Stroka K, Vitole M, Huso D, Martin S, Konstantopoulos K. Abstract 3259: Giant obscurins: Novel tumor and metastasis suppressors in breast cancer Cancer Research. 75: 3259-3259. DOI: 10.1158/1538-7445.Am2015-3259 |
0.763 |
|
2014 |
Ackermann MA, Shriver M, Perry NA, Hu LY, Kontrogianni-Konstantopoulos A. Obscurins: Goliaths and Davids take over non-muscle tissues. Plos One. 9: e88162. PMID 24516603 DOI: 10.1371/Journal.Pone.0088162 |
0.743 |
|
2013 |
Perry NA, Ackermann MA, Shriver M, Hu LY, Kontrogianni-Konstantopoulos A. Obscurins: unassuming giants enter the spotlight. Iubmb Life. 65: 479-86. PMID 23512348 DOI: 10.1002/Iub.1157 |
0.753 |
|
2013 |
Shriver M, Stroka K, Konstantopoulos K, Kontrogianni-Konstantopoulos A. Abstract 297: Loss of giant obscurins expression in breast epithelium disrupts epithelial junctions and promotes cell motility and invasion. Cancer Research. 73: 297-297. DOI: 10.1158/1538-7445.Am2013-297 |
0.724 |
|
2013 |
Ackermann MA, Hu LR, Hecker PA, Contreras M, Perry NA, Shriver M, O'Connell KA, Stanley WC, Kontrogianni-Konstantopoulos A. Obscurin: A New Player in Cardiac Hypertrophy Biophysical Journal. 104: 187a. DOI: 10.1016/J.Bpj.2012.11.1055 |
0.673 |
|
2012 |
Perry NA, Shriver M, Mameza MG, Grabias B, Balzer E, Kontrogianni-Konstantopoulos A. Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 2764-75. PMID 22441987 DOI: 10.1096/Fj.12-205419 |
0.765 |
|
2012 |
Perry NA, Shriver M, Mameza MG, Grabias B, Balzer E, Kontrogianni-Konstantopoulos A. Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance (FASEB Journal (2012) DOI: 10.1096/fj.12-205419) Faseb Journal. 26: 3931. DOI: 10.1096/fj.12-205419err |
0.737 |
|
Show low-probability matches. |